Back
Biogen Stock Predictions
Sponsored
BIIB
Sponsored
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
39
BIIB
Biogen
Last Price:
$148.85
Seasonality Move:
0.94%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock FreeBiogen Stock Forecast
-
Over the next 52 weeks, Biogen has on average historically risen by 40.7% based on the past 33 years of stock performance.
-
Biogen has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Biogen Stock Undervalued?The current Biogen [BIIB] share price is $150.75. The Score for BIIB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Biogen Stock Go Up Next Year?
-
Over the next 52 weeks, Biogen has on average historically risen by 40.7% based on the past 33 years of stock performance.
Biogen Stock Rating
Sell
39
Biogen (BIIB)
is a Sell
Is Biogen overpriced?
-
Biogen has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Biogen Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
255.18
52-Week Low:
145.07
Prediction Charts
Market Cap:
21.6B
Price in USD:
150.75
Volume:
1M
Beta:
0.93
Technical Analysis
SMA50:
160.09
SMA100:
177.78
SMA200:
197.62
52-Wk Change:
-41.57%
Stock Predictions
-
Is Biogen stock public?Yes, Biogen is a publicly traded company.
-
What is the Biogen stock quote today?The Biogen stock price is 150.75 USD today.
-
How to buy Biogen stock online?You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-18 | 150.01 | 146.79 | 151.49 | 146.58 |
Dec-19 | 146.60 | 147.39 | 148.25 | 145.24 |
Dec-20 | 145.64 | 146.47 | 147.85 | 145.07 |
Dec-23 | 146.00 | 149.38 | 149.92 | 145.52 |
Dec-24 | 148.67 | 149.02 | 149.41 | 147.07 |
Dec-26 | 148.00 | 149.90 | 150.68 | 147.83 |
Dec-27 | 148.74 | 151.31 | 151.88 | 148.23 |
Dec-30 | 150.92 | 150.19 | 151.18 | 148.19 |
Dec-31 | 150.80 | 152.92 | 153.04 | 150.19 |
Jan-2 | 153.84 | 150.00 | 154.12 | 149.84 |
Jan-3 | 149.73 | 152.21 | 152.97 | 149.73 |
Jan-6 | 151.93 | 153.27 | 153.60 | 151.62 |
Jan-7 | 153.11 | 153.15 | 156.37 | 152.90 |
Jan-8 | 152.27 | 150.75 | 152.82 | 150.07 |
Biogen Earnings
Biogen Earnings Report: Per Share Biogen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen Forecast Revenue Growth
Biogen Stock Analysis: Historical quarterly revenues per share for Biogen and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.76 per share.
* Biogen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.